- Home
- PBYI vs PFD Comparison
PBYI vs PFD Comparison
Compare PBYI & PFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- PFD
- Stock Information
- Founded
- PBYI 2010
- PFD 1990
- Country
- PBYI United States
- PFD United States
- Employees
- PBYI N/A
- PFD N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- PFD Investment Managers
- Sector
- PBYI Health Care
- PFD Finance
- Exchange
- PBYI Nasdaq
- PFD Nasdaq
- Market Cap
- PBYI 145.3M
- PFD 147.0M
- IPO Year
- PBYI N/A
- PFD N/A
- Fundamental
- Price
- PBYI $2.91
- PFD $11.29
- Analyst Decision
- PBYI Strong Buy
- PFD
- Analyst Count
- PBYI 1
- PFD 0
- Target Price
- PBYI $7.00
- PFD N/A
- AVG Volume (30 Days)
- PBYI 288.9K
- PFD 33.2K
- Earning Date
- PBYI 02-27-2025
- PFD 01-01-0001
- Dividend Yield
- PBYI N/A
- PFD 6.30%
- EPS Growth
- PBYI 492.79
- PFD N/A
- EPS
- PBYI 0.47
- PFD N/A
- Revenue
- PBYI $243,569,000.00
- PFD N/A
- Revenue This Year
- PBYI N/A
- PFD N/A
- Revenue Next Year
- PBYI N/A
- PFD N/A
- P/E Ratio
- PBYI $6.24
- PFD N/A
- Revenue Growth
- PBYI 6.30
- PFD N/A
- 52 Week Low
- PBYI $2.23
- PFD $8.53
- 52 Week High
- PBYI $7.15
- PFD $11.18
- Technical
- Relative Strength Index (RSI)
- PBYI 48.76
- PFD 47.67
- Support Level
- PBYI $2.69
- PFD $11.34
- Resistance Level
- PBYI $2.98
- PFD $11.46
- Average True Range (ATR)
- PBYI 0.12
- PFD 0.10
- MACD
- PBYI 0.01
- PFD 0.00
- Stochastic Oscillator
- PBYI 58.11
- PFD 66.67
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About PFD Flaherty & Crumrine Preferred and Income Fund Incorporated
Flaherty & Crumrine Prefd Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities, which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.